Armstrong, A. W. ., Lebwohl, M. ., Warren, R. B. ., Sofen, H. ., Morita, A. ., Imafuku, S. ., Ohtsuki, M. ., Spelman, L. ., Passeron, T. ., Papp, K. A. ., Colombo, M. J. ., Vaile, J. ., Vritzali, E. ., Hoyt, K. ., Daamen, C. ., Banerjee, S. ., Strober, B. ., Thaçi, D. . and Blauvelt, A. . (2024) “Deucravacitinib in Plaque Psoriasis: 4-Year Safety and Efficacy Results From the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials”, SKIN The Journal of Cutaneous Medicine, 8(4), p. s406. doi: 10.25251/skin.8.supp.406.